Current Trends in Antibody Drug Conjugates (ADCs) Characterization: Expert Paper

We bring you a brand-new paper focused on Current Trends in Antibody Drug Conjugates Characterization, focusing on structure.

Comprehensive structural, biophysical, and physico-chemical property characterization in alignment with Chemistry, Manufacturing and Controls (CMC) guidance is a requirement to achieve successful regulatory (IND) submissions. Multiple analytical technologies are required for ADC analysis with a focus on the drug’s critical quality attributes (CQA), with data interpretation conducted by experienced biopharmaceutical analytical scientists. In this review, we discuss the current trends in antibody drug conjugates characterization, and more.